Fidelity Investments
BHVN

Fidelity Investments’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Fidelity Investments’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-118,794
Closed -$18M – 5726
2022
Q3 		$18M Buy
118,794
+1,286
+1% +$191K ﹤0.01% 1648
2022
Q2 		$17.1M Sell
117,508
-1,434,343
-92% -$183M ﹤0.01% 1711
2022
Q1 		$184M Buy
1,551,851
+41,001
+3% +$5.11M 0.01% 819
2021
Q4 		$208M Buy
1,510,850
+229,600
+18% +$29.2M 0.02% 793
2021
Q3 		$178M Buy
1,281,250
+141,076
+12% +$17.6M 0.01% 857
2021
Q2 		$111M Buy
1,140,174
+21,950
+2% +$1.78M 0.01% 1081
2021
Q1 		$76.4M Sell
1,118,224
-235,913
-17% -$19.1M 0.01% 1191
2020
Q4 		$116M Sell
1,354,137
-25,880
-2% -$2.19M 0.01% 961
2020
Q3 		$89.7M Buy
1,380,017
+27,603
+2% +$1.81M 0.01% 962
2020
Q2 		$98.9M Buy
1,352,414
+562,071
+71% +$29.9M 0.01% 878
2020
Q1 		$26.9M Buy
790,343
+90,064
+13% +$4.12M ﹤0.01% 1287
2019
Q4 		$38.1M Hold
700,279
– – ﹤0.01% 1328
2019
Q3 		$29.2M Buy
700,279
+360,916
+106% +$15.2M ﹤0.01% 1419
2019
Q2 		$14.9M Sell
339,363
-117,004
-26% -$6.6M ﹤0.01% 1737
2019
Q1 		$23.5M Sell
456,367
-384,865
-46% -$16.6M ﹤0.01% 1533
2018
Q4 		$31.1M Sell
841,232
-57,600
-6% -$2.08M ﹤0.01% 1375
2018
Q3 		$33.8M Sell
898,832
-455,232
-34% -$16.7M ﹤0.01% 1466
2018
Q2 		$53.5M Buy
1,354,064
+846,141
+167% +$26.8M 0.01% 1245
2018
Q1 		$13.1M Sell
507,923
-527,600
-51% -$15.8M ﹤0.01% 1873
2017
Q4 		$27.9M Hold
1,035,523
– – ﹤0.01% 1562
2017
Q3 		$38.7M Hold
1,035,523
– – ﹤0.01% 1421
2017
Q2 		$25.9M Buy
+1,035,523
New +$23.8M ﹤0.01% 1574

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

Fidelity Investments's BHVN Position: Q4 2022 in Review

Fidelity Investments sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 118,794 shares — an estimated $18M sold.

Fidelity Investments first reported a position in BHVN in Q2 2017 and held it in 22 quarters. The position peaked at $208M in Q4 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Fidelity Investments reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Fidelity Investments sold 118,794 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $18M.
  • Fidelity Investments first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 22 quarters.
  • Fidelity Investments's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $208M in Q4 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Fidelity Investments's 13F filing for Q4 2022, filed 13 Feb 2023.